`United States Patent No. 8,293,742
`
`
`Petitioner’s Limitation By Limitation Claim Listing U.S. Patent No. 8,293,742
`No.
`Limitation
`A method for reducing eye redness
`1.P
`
`1.1
`
`1.2
`
`1.3
`
`2.P
`
`2.1
`
`3.P
`
`3.1
`
`3.2
`
`3.3
`
`3.4
`
`3.5
`
`3.6
`
`3.7
`
`4.P
`
`4.1
`
`5.P
`
`5.1
`
`consisting essentially of administering brimonidine
`
`to a patient having an ocular condition
`
`wherein the brimonidine is present at a concentration between about
`0.001% weight by volume and about 0.05% weight by volume
`
`The method of claim 1,
`
`wherein brimonidine is present at a concentration between about
`0.001% to about 0.025% weight by volume
`
`A method for reducing eye redness consisting essentially of
`
`topically administering to a patient having an ocular condition a
`composition
`
`to a patient having an ocular condition
`
`a composition consisting essentially of brimonidine
`
`into ocular tissue
`
`wherein pH of said composition is between about 5.5 and about 6.5,
`
`wherein said brimonidine concentration is between about 0.001% and
`about 0.025% weight by volume.
`
`and wherein said composition is formulated as an ocular drop
`
`The method of claim 3
`
`wherein said composition is topically administered within about 24
`hours after a Lasik surgery on said patient.
`
`The method of claim 1,
`
`wherein said ocular condition is chronic red eye
`
`
`
`
`
`
`
`Page 1 of 2
`
`SLAYBACK EXHIBIT 1036
`
`
`
`Inter Partes Review
`United States Patent No. 8,293,742
`
`Limitation
`
`The method of claim 3
`
`
`
`wherein said ocular condition is chronic red eye
`
`
`
`No.
`6.P
`
`6.1
`
`
`
`
`
`
`
`
`Page 2 of 2
`
`SLAYBACK EXHIBIT 1036
`
`